People: Bristol-Myers Squibb Co (BMYMP.PK)

BMYMP.PK on OTC Markets Group

901.56USD
25 Mar 2014
Price Change (% chg)

$-24.21 (-2.62%)
Prev Close
$925.77
Open
$901.56
Day's High
$901.56
Day's Low
$901.56
Volume
1
Avg. Vol
3
52-wk High
$997.09
52-wk Low
$829.79

Search Stocks

Heller, Frances 

Brief Biography

Ms. Frances K. Heller, J.D. is Senior Vice President - Business Development of Bristol-Myers Squibb Co. Prior to joining Bristol-Myers Squibb, Ms. Heller was executive vice president, Business Development at Exelixis. Prior to that, Ms. Heller was head of Strategic Alliances at Novartis Pharmaceuticals where she was responsible for transactions with partners in the pharmaceutical and biotech industry as well as academic institutions worldwide. Previously, she was Corporate and Intellectual Property counsel for Celera Genomics. Ms. Heller serves on the board of directors of several biotech companies and universities, is a Trustee at the Dana Farber Cancer Institute and teaches a business class at Stanford University on the biotech and pharmaceutical industry. Ms. Heller is a member of the California State Bar, is licensed by the U.S. Patent and Trademark Office, and has a B.S. in biology from Tulane University, an M.A. in biology from American University, and a J.D. from Golden Gate University School of Law.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Cornelius

10,859,000

Lamberto Andreotti

20,847,700

Charles Bancroft

7,878,020

Louis Schmukler

--

Francis Cuss

3,719,040

Giovanni Caforio

3,301,850
As Of 30 Dec 2013
Search Stocks